Payment & Shipping Terms:
|Product Name:||Exemestane||Other Name:||Aromasin|
|Function:||Anti Breast Cancer, Bodybuilding||Resend Policy:||Available|
tamoxifen citrate powder,
Pharma Grade Exemestane Anti Estrogen Steroids Best Dosage Aromasin Anti Breast Cancer
What is exemestane?
Exemestane is a steroidal Aromatase Inhibitor (AI) that is most commonly known as Aromasin. In fact, the Aromasin brand name is the only pharmaceutical grade brand of the Exemestane AI due to the tight patent Upjohn has maintained on the product. Exemestane lowers estrogen levels in postmenopausal women, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.
Exemestane is often given to women whose cancer has progressed even after surgery, radiation, or other cancer medications have been tried without success. Exemestane may also be used for purposes not listed in this medication guide.
Exemestane is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy.
Exemestane is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers.Exemestane is usually not used in women of childbearing age.
Benefits of Aromasin
Intergroup Exemestane Study trial was compared switching to Aromasin after taking tamoxifen for 2 to 3 years to staying on tamoxifen for 5 years. The results have shown that switching to Aromasin for 2 to 3 years AFTER taking tamoxifen 2 to 3 years (for a total of 5 years of hormonal therapy medicine) was better than staying on tamoxifen for 5 years for:
increasing the time before the cancer comes back in those who experience a recurrence
reducing the risk of a new cancer developing in the other breast
for postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer.
|Testosterone Sustanon 250|
|Nandrolone Decanoate (DECA)||360-70-3|
|Trenbolone Acetate (Finaplix H/Revalor-H)||10161-34-9|
|Boldenone Undecylenate (Equipoise)||13103-34-9|
|Methandrostenolone (Dianabol, methandienone,Dbol)||72-63-9|
Aromasin is officially classified as a steroidal suicide Aromatase Inhibitor, and carries the ability to inhibit the aromatase enzyme, which is responsible for the production or conversion of testosterone to estrogen. Aromasin has the ability to block aromatization, which in turn inhibits the production of estrogen, and thereby lowers the body’s serum estrogen levels. This will prove useful to breast cancer patients as breast cancer often feeds off the estrogen hormone. It will also prove useful to the anabolic steroid user.
Aromasin also has the ability to stimulate natural testosterone production, which is precisely why some will include it during their PCT. Like Arimidex and Letrozole, Aromasin will stimulate the pituitary to release more Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH), two hormones essential to natural testosterone production.
While the other common AI’s share this trait, Aromasin has been shown to carry a slight androgenic effect, as well as the ability to increase the production of Insulin-Like Growth Factor-1 (IGF-1). This is a trait no other AI can claim to carry. By using Aromasin during PCT, the individual receives the desired testosterone boost necessary for recovery, but with the IGF-1 increase also creates a stronger anabolic atmosphere.